{"entity":{"type":"insider","cik":"0001704342","url":"/insider/0001704342","json_url":"/insider/0001704342.json","name":"Wilson Martin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":17,"first":"2024-02-21","last":"2026-08-20","span_basis":"filed_date"},"name_variants":[{"name":"Wilson Martin","source":"filing","n_filings":17,"first_seen":"2024-02-21","last_seen":"2026-08-20"}],"transactions":[{"id":9299083,"accession":"0001140361-26-033915","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-26-033915","line_url":"/filing/0001140361-26-033915#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":631.0,"shares_display":"631","price_per_share":3.381,"price_display":"3.38","price_state":"stated","total_value":2133.411,"total_display":"2,133.41","total_whole":"2,133","shares_owned_after":673853.0,"shares_owned_after_display":"673,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-20","scope":"insider"},{"id":9233741,"accession":"0001140361-26-033413","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-26-033413","line_url":"/filing/0001140361-26-033413#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3493.0,"shares_display":"3,493","price_per_share":3.381,"price_display":"3.38","price_state":"stated","total_value":11809.833,"total_display":"11,809.83","total_whole":"11,810","shares_owned_after":674484.0,"shares_owned_after_display":"674,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-13","filed_date":"2026-08-17","scope":"insider"},{"id":6035305,"accession":"0001140361-26-022446","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-26-022446","line_url":"/filing/0001140361-26-022446#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":662.0,"shares_display":"662","price_per_share":3.014,"price_display":"3.01","price_state":"stated","total_value":1995.268,"total_display":"1,995.27","total_whole":"1,995","shares_owned_after":677977.0,"shares_owned_after_display":"677,977","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-19","filed_date":"2026-05-21","scope":"insider"},{"id":5808967,"accession":"0001140361-26-021321","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-26-021321","line_url":"/filing/0001140361-26-021321#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3361.0,"shares_display":"3,361","price_per_share":3.606,"price_display":"3.61","price_state":"stated","total_value":12119.766,"total_display":"12,119.77","total_whole":"12,120","shares_owned_after":678639.0,"shares_owned_after_display":"678,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-14","scope":"insider"},{"id":5769860,"accession":"0001140361-26-006317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-26-006317","line_url":"/filing/0001140361-26-006317#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1376.0,"shares_display":"1,376","price_per_share":3.338,"price_display":"3.34","price_state":"stated","total_value":4593.088,"total_display":"4,593.09","total_whole":"4,593","shares_owned_after":682000.0,"shares_owned_after_display":"682,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-20","scope":"insider"},{"id":6086150,"accession":"0001140361-26-006047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-26-006047","line_url":"/filing/0001140361-26-006047#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12253.0,"shares_display":"12,253","price_per_share":3.312,"price_display":"3.31","price_state":"stated","total_value":40581.936,"total_display":"40,581.94","total_whole":"40,582","shares_owned_after":683376.0,"shares_owned_after_display":"683,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-18","scope":"insider"},{"id":4989670,"accession":"0001140361-25-042854","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-042854","line_url":"/filing/0001140361-25-042854#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1646.0,"shares_display":"1,646","price_per_share":2.983,"price_display":"2.98","price_state":"stated","total_value":4910.018,"total_display":"4,910.02","total_whole":"4,910","shares_owned_after":383816.0,"shares_owned_after_display":"383,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-20","scope":"insider"},{"id":4270051,"accession":"0001140361-25-032090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-032090","line_url":"/filing/0001140361-25-032090#line-2","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":588.0,"shares_display":"588","price_per_share":2.996,"price_display":"3.00","price_state":"stated","total_value":1761.648,"total_display":"1,761.65","total_whole":"1,762","shares_owned_after":135462.0,"shares_owned_after_display":"135,462","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-19","filed_date":"2025-08-20","scope":"insider"},{"id":4270046,"accession":"0001140361-25-032090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-032090","line_url":"/filing/0001140361-25-032090#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1004.0,"shares_display":"1,004","price_per_share":3.065,"price_display":"3.06","price_state":"stated","total_value":3077.26,"total_display":"3,077.26","total_whole":"3,077","shares_owned_after":136050.0,"shares_owned_after_display":"136,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-20","scope":"insider"},{"id":4170577,"accession":"0001140361-25-031760","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-031760","line_url":"/filing/0001140361-25-031760#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12109.0,"shares_display":"12,109","price_per_share":3.019,"price_display":"3.02","price_state":"stated","total_value":36557.071,"total_display":"36,557.07","total_whole":"36,557","shares_owned_after":137054.0,"shares_owned_after_display":"137,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-14","filed_date":"2025-08-18","scope":"insider"},{"id":4844455,"accession":"0001140361-25-020159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-020159","line_url":"/filing/0001140361-25-020159#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":587.0,"shares_display":"587","price_per_share":6.446,"price_display":"6.45","price_state":"stated","total_value":3783.802,"total_display":"3,783.80","total_whole":"3,784","shares_owned_after":149163.0,"shares_owned_after_display":"149,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-22","scope":"insider"},{"id":4844449,"accession":"0001140361-25-019898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-019898","line_url":"/filing/0001140361-25-019898#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":946.0,"shares_display":"946","price_per_share":6.528,"price_display":"6.53","price_state":"stated","total_value":6175.488,"total_display":"6,175.49","total_whole":"6,175","shares_owned_after":149750.0,"shares_owned_after_display":"149,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-20","scope":"insider"},{"id":4577292,"accession":"0001140361-25-005846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-005846","line_url":"/filing/0001140361-25-005846#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3222.0,"shares_display":"3,222","price_per_share":10.58,"price_display":"10.58","price_state":"stated","total_value":34088.76,"total_display":"34,088.76","total_whole":"34,089","shares_owned_after":150696.0,"shares_owned_after_display":"150,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-21","filed_date":"2025-02-25","scope":"insider"},{"id":2584372,"accession":"0001140361-24-047754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-24-047754","line_url":"/filing/0001140361-24-047754#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1175.0,"shares_display":"1,175","price_per_share":13.054,"price_display":"13.05","price_state":"stated","total_value":15338.45,"total_display":"15,338.45","total_whole":"15,338","shares_owned_after":63560.0,"shares_owned_after_display":"63,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-21","filed_date":"2024-11-25","scope":"insider"},{"id":2036415,"accession":"0001140361-24-037931","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-24-037931","line_url":"/filing/0001140361-24-037931#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1027.0,"shares_display":"1,027","price_per_share":18.504,"price_display":"18.50","price_state":"stated","total_value":19003.608,"total_display":"19,003.61","total_whole":"19,004","shares_owned_after":64735.0,"shares_owned_after_display":"64,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-20","scope":"insider"},{"id":2841867,"accession":"0001140361-24-026873","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-24-026873","line_url":"/filing/0001140361-24-026873#line-4","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1048.0,"shares_display":"1,048","price_per_share":23.35,"price_display":"23.35","price_state":"stated","total_value":24470.8,"total_display":"24,470.80","total_whole":"24,471","shares_owned_after":65762.0,"shares_owned_after_display":"65,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":2209529,"accession":"0001140361-24-011168","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-24-011168","line_url":"/filing/0001140361-24-011168#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":29.331,"price_display":"29.33","price_state":"stated","total_value":120257.1,"total_display":"120,257.10","total_whole":"120,257","shares_owned_after":18680.0,"shares_owned_after_display":"18,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-04","scope":"insider"},{"id":2980542,"accession":"0001140361-24-008890","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-24-008890","line_url":"/filing/0001140361-24-008890#line-2","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001704342","owner_name":"Wilson Martin","owner_display_name":"Wilson Martin","owner_url":"/insider/0001704342","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3576.0,"shares_display":"3,576","price_per_share":29.838,"price_display":"29.84","price_state":"stated","total_value":106700.688,"total_display":"106,700.69","total_whole":"106,701","shares_owned_after":6136.0,"shares_owned_after_display":"6,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001281895","name":"ROCKET PHARMACEUTICALS, INC.","url":"/issuer/0001281895","role":"Officer (General Counsel)","n_filings":17,"first_seen":"2024-02-21","last_seen":"2026-08-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001704342","retrieved_at":"2026-08-24T01:40:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}